Cargando…

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Seeding and spread of beta-amyloid (Aβ) pathologies have been considered to be based on prion-like mechanisms. However, limited transmissibility of Aβ seeding activity upon peripheral exposure would represent a key difference to prions, not only in terms of pathogenesis but also in terms of potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Burwinkel, Michael, Lutzenberger, Manuel, Heppner, Frank L., Schulz-Schaeffer, Walter, Baier, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836327/
https://www.ncbi.nlm.nih.gov/pubmed/29506560
http://dx.doi.org/10.1186/s40478-018-0511-7
_version_ 1783303942031015936
author Burwinkel, Michael
Lutzenberger, Manuel
Heppner, Frank L.
Schulz-Schaeffer, Walter
Baier, Michael
author_facet Burwinkel, Michael
Lutzenberger, Manuel
Heppner, Frank L.
Schulz-Schaeffer, Walter
Baier, Michael
author_sort Burwinkel, Michael
collection PubMed
description Seeding and spread of beta-amyloid (Aβ) pathologies have been considered to be based on prion-like mechanisms. However, limited transmissibility of Aβ seeding activity upon peripheral exposure would represent a key difference to prions, not only in terms of pathogenesis but also in terms of potential transmission of disease. We partially characterized the seeded Aβ amyloidosis after intracerebral injection of various brain homogenates in APP/PS1 mice. One particularly seed-laden homogenate was selected to investigate the development of Aβ pathologies after intravenous exposure. We report here that a single intravenous injection of an Alzheimer disease patient’s-brain extract into APP/PS1 recipient mice led to cerebral amyloid angiopathy within 180 days post injection. Thus, vascular proteinopathies such as CAA are transmissible in mice via the intravenous route of peripheral exposure.
format Online
Article
Text
id pubmed-5836327
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58363272018-03-07 Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) Burwinkel, Michael Lutzenberger, Manuel Heppner, Frank L. Schulz-Schaeffer, Walter Baier, Michael Acta Neuropathol Commun Research Seeding and spread of beta-amyloid (Aβ) pathologies have been considered to be based on prion-like mechanisms. However, limited transmissibility of Aβ seeding activity upon peripheral exposure would represent a key difference to prions, not only in terms of pathogenesis but also in terms of potential transmission of disease. We partially characterized the seeded Aβ amyloidosis after intracerebral injection of various brain homogenates in APP/PS1 mice. One particularly seed-laden homogenate was selected to investigate the development of Aβ pathologies after intravenous exposure. We report here that a single intravenous injection of an Alzheimer disease patient’s-brain extract into APP/PS1 recipient mice led to cerebral amyloid angiopathy within 180 days post injection. Thus, vascular proteinopathies such as CAA are transmissible in mice via the intravenous route of peripheral exposure. BioMed Central 2018-03-05 /pmc/articles/PMC5836327/ /pubmed/29506560 http://dx.doi.org/10.1186/s40478-018-0511-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Burwinkel, Michael
Lutzenberger, Manuel
Heppner, Frank L.
Schulz-Schaeffer, Walter
Baier, Michael
Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
title Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
title_full Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
title_fullStr Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
title_full_unstemmed Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
title_short Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)
title_sort intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (caa)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836327/
https://www.ncbi.nlm.nih.gov/pubmed/29506560
http://dx.doi.org/10.1186/s40478-018-0511-7
work_keys_str_mv AT burwinkelmichael intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa
AT lutzenbergermanuel intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa
AT heppnerfrankl intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa
AT schulzschaefferwalter intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa
AT baiermichael intravenousinjectionofbetaamyloidseedspromotescerebralamyloidangiopathycaa